Sars-Cov-2 Jn.1 Mrna

ATC — · 2 markets · 3 records

Sars-Cov-2 Jn.1 Mrna 2 markets · 3 records Forms

AU 2 records · 2 strengths

Records without a stated strength · 2 SPIKEVAX JN.1 SPIKEVAX JN.1 (SARS-CoV-2 JN.1 mRNA) COVID-19 VACCINE 0.1 mg/mL suspension for injection pre-filled syringe

HK 1 records · 1 strengths

Records without a stated strength · 1 SPIKEVAX JN.1 DISPERSION FOR INJECTION IN PRE-FILLED SYRINGE COVID-19 MRNA VACCINE 50 MICROGRAMS/DOSE 0.5ML

Side-by-side table

Strength / form / release	AU	HK
not disclosed unknown	SPIKEVAX JN.1	SPIKEVAX JN.1 DISPERSION FOR INJECTION IN PRE-FILLED SYRINGE COVID-19 MRNA VACCINE 50 MICROGRAMS/DOSE 0.5ML
not disclosed injection	SPIKEVAX JN.1 (SARS-CoV-2 JN.1 mRNA) COVID-19 VACCINE 0.1 mg/mL suspension for injection pre-filled syringe	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.